Clinical Trial Update: In Vivo PARP-1 Expression With 18F-FluorThanatrace PET/CT in Patients With Pheochromocytoma and Paraganglioma [EARLY_Phase 1]

View source ↗

Summary

Early-phase 1 imaging study evaluating PARP-1 expression using 18F-FluorThanatrace PET/CT in patients with pheochromocytoma and paraganglioma; currently recruit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Paraganglioma
• Pheochromocytoma

Snippet

Sponsor: Heather Wachtel | Conditions: Pheochromocytoma, Paraganglioma | EARLY_Phase 1 | Status: RECRUITING